Graft-versus-Host Disease in Myeloma
What Is Graft-versus-Host Disease (GvHD) in Myeloma Patients?
Find out the answer from Canadian myeloma expert:
Dennis Kim, MD, PhD
Leukemia & Allogeneic BMT Programs
Princess Margaret Cancer Centre
University of Toronto, ON
_________
Founded in 2005, Myeloma Canada is the only national patient-focused charitable organization dedicated to addressing the holistic needs of people impacted by multiple myeloma. Guided by its vision of a life uninterrupted by myeloma, it works to improve lives, increase access to optimal care, and advance research toward a cure.
For more information, visit: https://www.myeloma.ca
#MultipleMyeloma #GraftVersusHostDisease #GvHD #AllogeneicSCT #SCT #StemCellTransplant